Albert Liu, MD, MPH
Dr. Albert Liu is the Clinical Research Director of Bridge HIV within the San Francisco Department of Public Health and Clinical Professor of Medicine at UCSF. His research focuses on conducting clinical trials of novel PrEP agents, developing strategies to monitor and support PrEP adherence, and evaluating implementation strategies to support the equitable scale-up of PrEP and RAPID ART. He is an investigator within the HIV Prevention Trials Network and COVID Prevention Trials Network. He also serves as co-chair of the PrEP Committee of the San Francisco Getting to Zero Consortium and a member of the UCSF IRB.
Natalie Wilson, PhD, DNP, MPH, APRN-BC
Dr. Natalie Wilson is an Assistant Professor of Nursing in the Department of Community Health Systems at the UCSF School of Nursing. Dr. Wilson’s research is informed by over 27 years of clinical expertise in primary care, HIV, and sexual health. As part of the Ending the HIV Epidemic National Strategy, she will focus on developing innovative solutions to address the constraints marginalized populations and those from disadvantaged socioeconomic environments have in accessing the HIV Status Neutral Care Continuum. She uses community engagement and mixed-methods implementation science methods to transform healthcare by building in health equity at the individual, system, and community levels. Dr. Wilson also conducts research in HIV Symptom Clusters and how phytocannabinoids may be used to mitigate symptoms and inflammation. Dr. Wilson received her doctoral degrees from the University of Alabama at Birmingham, master’s degrees of Nursing and Public Health from Vanderbilt University and UNC-Chapel respectively, and her bachelor’s degree from Spelman College.